SCHEMBL7708055

SCHEMBL7708055

CC1Oc2ccc(C(Cc3ccccc3Cl)NC(=O)OC(C)(C)C)cc2NC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 4/20 0.41
IDO1 P14902 1/20 0.39
MC4R P32245 1/20 0.37
SMYD3 Q9H7B4 3/20 0.37
KDR P35968 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
RCE1 Q9Y256 1/20 0.36
CCKAR P32238 1/20 0.36
CCKBR P32239 1/20 0.36
PLA2G1B P04054 1/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
XBP1 P17861 1/20 0.35
HTT P42858 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
ATG4B Q9Y4P1 1/20 0.35
HSD17B10 Q99714 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7087735 0.91 MC4R (0.36) IDO1MC4RKDM4EALDH1A1RCE1
SCHEMBL7708210 0.91 MC4R (0.41) PARP1IDO1MC4RSMYD3KDR
SCHEMBL7708086 0.90 CTSS (0.43) PARP1IDO1SMYD3KDM4EALDH1A1
SCHEMBL7713374 0.88 PARP1 (0.50) PARP1IDO1ALDH1A1CCKARCCKBR
SCHEMBL7710779 0.87 TP53 (0.40) PARP1IDO1SMYD3KDRKDM4E
SCHEMBL7704807 0.87 HSD17B10 (0.42) PARP1IDO1SMYD3KDRMAPT
SCHEMBL7713423 0.86 PARP1 (0.41) PARP1IDO1SMYD3KDRALDH1A1
SCHEMBL7713338 0.86 PARP1 (0.42) PARP1IDO1SMYD3KDRALDH1A1
SCHEMBL7711137 0.85 CTSL (0.45) PARP1IDO1SMYD3KDRKDM4E
SCHEMBL7713294 0.83 PARP1 (0.42) PARP1IDO1SMYD3ALDH1A1CCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed